Here is the synopsis of our sample research paper on Should New Drugs Be Labelled As ‘New’ To Indicate A Higher Risk Than Established Dugs?. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 4 page paper considers the issue of new drugs and whether or not they should be labelled as an issue of public safety. The FDA focuses on drug approval, leaving a gap when it comes to assessing drugs that have already been approved. There ahs been a call for all new drugs to be marked as new. The paper assesses this from the perspective of the drug companies, the health policy makers and the patients. The bibliography cites 2 sources.
Page Count:
4 pages (~225 words per page)
File: TS14_TEnewdrug.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
Drug Administration (FDA) are charged with ensuring that drugs are safe, the majority of their efforts are focused on the approval system used to approve new drugs. This is a
system that is robust and seeks to ensure public safety as far as possible and a system that has many pressures from the drug companies as well as the public
pressures from stakeholders who want the new drugs available. However, cases such as Vioxx indicate that despite many clinical trials there are some problems which may not emerge until after
the drugs have been in the public domain for some time (Mathews, 2007). The problem is that there is insufficient monitoring and control of drugs after they have been approved.
Without an aggressive and proactive system in place it is quiet possible that more problem such as Vioxx will occur with drugs causing health problems and even unnecessary death and
at the current time there is o way that a drug is identified as being one that is new and potentially more risky. What is the implementation of
this issue? Under the current system it is the job of the FDA, however, there is a major bias of the funds used to ensure drug safety focused in
the approval of new drugs. After a drug is approved there are few quality reports undertaken to test the safety of the drug. The tests which are undertaken by the
drug companies trend to be focused in the issues concerned with increasing the sales of the drug. The current system is simple, once the drug has received approval it
is available to be prescribed, bring both the benefits of the new treatment to the market as well as the potential risks. However as there is not indication that the
...